Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
Status:
Completed
Trial end date:
2018-12-22
Target enrollment:
Participant gender:
Summary
This is a phase 1, randomized, open label, single-dose, replicate crossover clinical trial to
compare the safety and pharmacokinetics of YH22162 in healthy male volunteers.
Hypothesis: Study drug and comparator drug are showing equal pharmacokinetics.